<DOC>
	<DOC>NCT00301431</DOC>
	<brief_summary>The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.</brief_summary>
	<brief_title>Study Evaluating the Efficacy of DVS-233 in Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Fibromyalgia according to 1990 American College of Rheumatology (ACR) criteria Other painful conditions that may make results difficult to interpret. Treatment with other drugs for fibromyalgia with 14 days of study start or during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Adults</keyword>
	<keyword>Outpatients</keyword>
	<keyword>Adult</keyword>
	<keyword>Double-Blind Method</keyword>
</DOC>